Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 5180579, 9 pages
https://doi.org/10.1155/2017/5180579
Research Article

Human Chorionic Plate-Derived Mesenchymal Stem Cells Restore Hepatic Lipid Metabolism in a Rat Model of Bile Duct Ligation

1Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
2Department of Biomedical Science, CHA University, Seongnam, Republic of Korea
3Department of Dermatology, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
4Clinical Research Center, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
5Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea

Correspondence should be addressed to Jung-Hwan Yoon; rk.ca.uns@hjnooy and Gi Jin Kim; rk.ca.ahc@mikjg

Received 28 July 2017; Accepted 2 October 2017; Published 9 November 2017

Academic Editor: Mohamed Abumaree

Copyright © 2017 Yun Bin Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Manos, W. A. Leyden, R. C. Murphy, N. A. Terrault, and B. P. Bell, “Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment,” Hepatology, vol. 47, no. 4, pp. 1150–1157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Trauner, P. J. Meier, and J. L. Boyer, “Molecular pathogenesis of cholestasis,” The New England Journal of Medicine, vol. 339, no. 17, pp. 1217–1227, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. K. B. Lee, “Histopathology of a benign bile duct lesion in the liver: morphologic mimicker or precursor of intrahepatic cholangiocarcinoma,” Clinical and Molecular Hepatology, vol. 22, no. 3, pp. 400–405, 2016. View at Publisher · View at Google Scholar
  4. S. R. De Vriese, J. L. Savelii, J. P. Poisson et al., “Fat absorption and metabolism in bile duct ligated rats,” Annals of Nutrition & Metabolism, vol. 45, no. 5, pp. 209–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Kamisako and H. Ogawa, “Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat: disappearance of abcg5 and abcg8 mRNA after bile duct ligation,” Hepatology Research, vol. 25, no. 2, pp. 99–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Prockop, “Marrow stromal cells as stem cells for nonhematopoietic tissues,” Science, vol. 276, no. 5309, pp. 71–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, and K. Tsuji, “Human placenta-derived cells have mesenchymal stem/progenitor cell potential,” Stem Cells, vol. 22, no. 5, pp. 649–658, 2004. View at Publisher · View at Google Scholar
  8. H. J. Lee, K. E. Cha, S. G. Hwang, J. K. Kim, and G. J. Kim, “In vitro screening system for hepatotoxicity: comparison of bone-marrow-derived mesenchymal stem cells and placenta-derived stem cells,” Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 49–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Kim, K. S. Shin, J. H. Jeon et al., “Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells,” Cell and Tissue Research, vol. 346, no. 1, pp. 53–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Lee, J. Jung, K. H. Na et al., “Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4-injured liver: potential application to the treatment of hepatic diseases,” Journal of Cellular Biochemistry, vol. 111, no. 6, pp. 1453–1463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Jung, J. H. Choi, Y. Lee et al., “Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4-injured rat liver model via increased autophagic mechanism,” Stem Cells, vol. 31, no. 8, pp. 1584–1596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Mahmoud, S. E. Swefy, R. A. Hasan, and A. Ibrahim, “Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats,” European Journal of Pharmacology, vol. 742, pp. 118–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. H. Jun, J. H. Choi, S. H. Bae, S. H. Oh, and G. J. Kim, “Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation,” Clinical and Molecular Hepatology, vol. 22, no. 3, pp. 372–381, 2016. View at Publisher · View at Google Scholar
  14. J. Jung, J. W. Moon, J. H. Choi, Y. W. Lee, S. H. Park, and G. J. Kim, “Epigenetic alterations of IL-6/STAT3 signaling by placental stem cells promote hepatic regeneration in a rat model with CCl4-induced liver injury,” International Journal of Stem Cells, vol. 8, no. 1, pp. 79–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Storch and B. Corsico, “The emerging functions and mechanisms of mammalian fatty acid–binding proteins,” Annual Review of Nutrition, vol. 28, pp. 73–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. A. Watkins, “Fatty acid activation,” Progress in Lipid Research, vol. 36, no. 1, pp. 55–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Mashek, L. O. Li, and R. A. Coleman, “Long-chain acyl-CoA synthetases and fatty acid channeling,” Future Lipidology, vol. 2, no. 4, pp. 465–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. M. Lewin, J. H. Kim, D. A. Granger, J. E. Vance, and R. A. Coleman, “Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently,” Journal of Biological Chemistry, vol. 276, no. 27, pp. 24674–24679, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. Heinzer, S. Kemp, J. F. Lu, P. A. Watkins, and K. D. Smith, “Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy,” Journal of Biological Chemistry, vol. 277, no. 32, pp. 28765–28773, 2002. View at Publisher · View at Google Scholar
  20. H. Doege, R. A. Baillie, A. M. Ortegon et al., “Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis,” Gastroenterology, vol. 130, no. 4, pp. 1245–1258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Svegliati-Baroni, S. Saccomanno, C. Rychlicki et al., “Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis,” Liver International, vol. 31, no. 9, pp. 1285–1297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Pawlak, P. Lefebvre, and B. Staels, “Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 62, no. 3, pp. 720–733, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. K. J. Rayner, C. C. Esau, F. N. Hussain et al., “Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides,” Nature, vol. 478, no. 7369, pp. 404–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jais, E. Einwallner, O. Sharif et al., “Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man,” Cell, vol. 158, no. 1, pp. 25–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Moustafa, P. Fickert, C. Magnes et al., “Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury,” Gastroenterology, vol. 142, no. 1, pp. 140–151.e12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Nassir and J. A. Ibdah, “Role of mitochondria in nonalcoholic fatty liver disease,” International Journal of Molecular Sciences, vol. 15, no. 5, pp. 8713–8742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Yan, D. Li, T. Chen, G. Tian, P. Zhou, and X. Ju, “Umbilical cord MSCs reverse D-galactose-induced hepatic mitochondrial dysfunction via activation of Nrf2/HO-1 pathway,” Biological and Pharmaceutical Bulletin, vol. 40, no. 8, pp. 1174–1182, 2017. View at Publisher · View at Google Scholar